Literature DB >> 24284654

Loss of ASAP3 destabilizes cytoskeletal protein ACTG1 to suppress cancer cell migration.

Yu Luo1, Fang Kong2, Zhen Wang2, Dahan Chen2, Qiuyan Liu3, Tao Wang2, Ruian Xu3, Xianyuan Wang1, James Y Yang2.   

Abstract

ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 (ASAP3), previously known as ACAP4, DDEFL1 and UPLC1, is considered to be an important regulator in cancer cell migration/invasion and actin-based cytoskeletal remodeling. However, the underlying mechanisms through which ASAP3 mediates these processes are not well-elucidated. This study reported that in certain types of cancer cells, loss of ASAP3 suppressed cell migration/invasion, in part by destabilizing γ-actin-1 (ACTG1), a cytoskeletal protein considered to be an integral component of the cell migratory machinery, essential for the rearrangement of the dynamic cytoskeletal networks and important in diseases, such as brain malformation, hearing loss and cancer development. The data, for the first time, link ASAP3 with ACTG1 in the regulation of cytoskeletal maintenance and cell motility.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284654     DOI: 10.3892/mmr.2013.1831

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing.

Authors:  Peng Song; Wenbin Li; Lei Guo; Jianming Ying; Shugeng Gao; Jie He
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

2.  Genome analysis of Excretory/Secretory proteins in Taenia solium reveals their Abundance of Antigenic Regions (AAR).

Authors:  Sandra Gomez; Laura Adalid-Peralta; Hector Palafox-Fonseca; Vito Adrian Cantu-Robles; Xavier Soberón; Edda Sciutto; Gladis Fragoso; Raúl J Bobes; Juan P Laclette; Luis del Pozo Yauner; Adrián Ochoa-Leyva
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

3.  A computational strategy to select optimized protein targets for drug development toward the control of cancer diseases.

Authors:  Nicolas Carels; Tatiana Tilli; Jack A Tuszynski
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

4.  Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome.

Authors:  Haiying Tian; Jin Qian; Luoyan Ai; Yueyuan Li; Wenyu Su; Xian-Ming Kong; Jie Xu; Jing-Yuan Fang
Journal:  Cancer Sci       Date:  2017-06-14       Impact factor: 6.716

5.  Exosomes impact survival to radiation exposure in cell line models of nervous system cancer.

Authors:  Oliver D Mrowczynski; Achuthamangalam B Madhankumar; Jeffrey M Sundstrom; Yuanjun Zhao; Yuka Imamura Kawasawa; Becky Slagle-Webb; Christine Mau; Russell A Payne; Elias B Rizk; Brad E Zacharia; James R Connor
Journal:  Oncotarget       Date:  2018-11-16

6.  Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.

Authors:  Yichen Song; Lianqi Shao; Yixue Xue; Xuelei Ruan; Xiaobai Liu; Chunqing Yang; Jian Zheng; Shuyuan Shen; Jiajia Chen; Zhen Li; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-06-11

7.  ASAP3 is a downstream target of HIF-1α and is critical for progression of lung adenocarcinoma.

Authors:  Pingping Zhang; Junwei Sun; Jindan Kai; Yi Peng; Xiyou Liu; Fuxiang Zhou; Jianping Wu
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

8.  Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.

Authors:  Chang-In Moon; William Tompkins; Yuxi Wang; Abigail Godec; Xiaochun Zhang; Patrik Pipkorn; Christopher A Miller; Carina Dehner; Sonika Dahiya; Angela C Hirbe
Journal:  Genes (Basel)       Date:  2020-05-01       Impact factor: 4.096

9.  DDEFL1 correlated with Rho GTPases activity in breast cancer.

Authors:  Xiaoyun Mao; Chuifeng Fan; Xinmiao Yu; Bo Chen; Feng Jin
Journal:  Oncotarget       Date:  2017-10-26

10.  Integrative proteomic and phosphoproteomic profiling of prostate cell lines.

Authors:  Maria Katsogiannou; Jean-Baptiste Boyer; Alberto Valdeolivas; Elisabeth Remy; Laurence Calzone; Stéphane Audebert; Palma Rocchi; Luc Camoin; Anaïs Baudot
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.